The EU has funded the new Doctoral Network “MITGEST” (Quality Control of the Mitochondrial Gene Expression System in Health and Disease). Supported under the Marie
MORE →Our uniqueness
baseclick’s proprietary click chemistry is the most streamlined and simplified bioconjugation method in life science. Our breakthrough in CuAAC or SPAAC, the so called click reaction, results in a convenient, versatile and reliable single step covalent coupling. The reactions require simple or no workup or purification of the product. We have developed highly efficient methods and protocols and a series of optimized ClickTech assay kits to create highly modified DNA and RNA. Our applications, customer services and tools demonstrate the superiority of patent protected platform.
Our highlights
- Click chemistry in oligonucleotide synthesis enables labeling up to 99.99% yield.
- The most versatile click chemistry portfolio of chemical tools including clickable dyes, sugars, fatty acids, amino acids, biotin and more to advance innovative projects
- Our EdU cell proliferation assays provide a superior alternative to BrdU assays. For monitoring of cell vitality, determining genotoxicity or evaluating anticancer drugs.
- Our technology enables 5’, 3’, dual, multi or internally labeled DNA or RNA sequences used in our FISH Kits and PCR Kits.
- Click chemistry in Next Generation Sequencing enables-for the first time – complete full-length information from 5’ to 3’ in transcriptomics and is compatible with all available sequencing devices.
Our lab expertise in click chemistry of nucleic acid drug and vaccine development is also available as a service
- Our specialized custom oligonucleotide service to produce drug substances like aptamers, siRNA and more
- Specific cellular uptake can be achieved with mRNA clicked to targeting agents and generated via our mRNA production service
Directly to our products and services
Partner
Science
18
Jul
Lecture at iCA PhD Program
On 28 June 2022, our CEO Dr. Thomas Frischmuth gave the lecture “Strategies to control COVID-19 pandemic and disease – nucleic acids-based vaccines and drugs”
MORE →On 24 June 2022, our scientists Fabio Spada and Eva Schönegger will attend the workshop on New RNA Therapeutics at Center for Advanced Studies (CAS)
MORE →